www.selfieai.world
Confidential | For Investor Use Only
Private & Confidential
The information in these documents is confidential and privileged, intended only for the designated recipient. Unauthorized use, publication, or redistribution without Selfie Ai Sdn. Bhd.'s written consent is strictly prohibited.
The contents, which may include facts and opinions, are subject to change. While accuracy is ensured, you should seek independent advice before making investment decisions.
Selfie Ai Sdn. Bhd. makes no representations or warranties, express or implied, and is not responsible or liable for any loss, damage, costs, or expenses incurred by you as a result of relying on the information provided.
To redefine preventive healthcare by enabling everyone to assess their health status through a selfie.
To eliminate diabetic blindness by making early-stage retinopathy screening accessible, affordable, and AI-powered through mobile devices.
Selfie AI embodies a transformative approach to preventive healthcare, merging advanced AI technology with the simplicity of a selfie. Our brand stands at the intersection of innovation and accessibility, aiming to democratize health diagnostics.
Enabling individuals to take charge of their health through accessible technology.
Continuously advancing AI capabilities to provide accurate and timely diagnostics.
Breaking down barriers to healthcare by offering affordable and user-friendly solutions.
The Selfie AI logo features a sleek, modern design with a stylized Selfie icon, symbolizing precision and clarity in diagnostics.
"Your Health. One Selfie Away."
Selfie AI is forward-thinking, trustworthy, and compassionate. We strive to make complex health diagnostics simple and available to all, ensuring early detection and better health outcomes.
Selfie AI doesn't just detect disease—it prevents blindness before it happens. We're unlocking a $50B global market in AI diagnostics by solving a high-cost, high-impact problem with low-friction technology.
🌍 Global Market Potential: $50B
537 million diabetics worldwide (IDF, 2023)
TAM: $52.5B
Based on 179M needing annual DR screening
90 million diabetics across SEA
SAM: $5.4B
Annual diagnostic need at ~$30 per patient
3.9 million Malaysians with diabetes
SOM: $45M/year
RM 10 per screening + RM 150/month leasing
| DR Stage | % of Diabetic Patients | Avg Screenings/Year | Estimated Screenings (per 1M Diabetics) |
|---|---|---|---|
| No DR / Mild NPDR | 60% | 1 | 600,000 |
| Moderate NPDR | 20% | 2 | 400,000 |
| Severe NPDR / PDR / DME | 15% | 3–4 | 525,000 |
| Treated / Monitoring | 5% | 3 | 150,000 |
| Total Avg / Diabetic | — | ~1.75 | ~1.75M scans/year per 1M diabetics |
Selfie AI transforms this scenario with:
(Diagram would show the complete flow from image capture to EMR integration with AI processing in between)
| Revenue Stream | Model | Price/Unit | Description |
|---|---|---|---|
| API-based screening | Per scan | RM 10 | Real-time AI analysis charged per diagnostic session |
| Device leasing | Monthly | RM 150/device | Camera + app license bundled into recurring lease |
| Institutional licensing | Annual | RM 10,000–50,000 | Tiered licenses for NGOs, public hospitals, and group clinics |
| Dashboard Analytics | Subscription | RM 500–2,000/month | Insights into patient trends, location coverage, etc. |
| EMR Integration | One-time + support | RM 3,000–15,000 | Setup and maintenance of custom integrations |
| Engagement Type | Value Proposition | Estimated Contract Size |
|---|---|---|
| MOH Diabetic Screening Pilot | Deploy Selfie AI across 100 clinics | RM 1.5M–3M |
| State-level DR Programs | Leased devices + API use | RM 200K–500K/state |
| PPP Model | Selfie AI handles infrastructure, govt funds scans | RM 10M+ nationally over 2–3 years |
Embedded AI + Field-Ready Simplicity = Scalable Diagnostic Infrastructure Without the Infrastructure
Selfie AI uniquely combines a YOLOv5-trained deep learning model with a smartphone-compatible fundus camera, delivering real-time diagnostic-grade diabetic retinopathy detection—without the need for a specialist or high-end infrastructure.
While AI diagnostics exist, few can run offline, deliver under RM 10 per scan, operate without doctors or Wi-Fi, and be embedded seamlessly into public health systems. Selfie AI is designed from the ground up for emerging markets.
Each scan helps rettrain and refine the model with localized population data, creating a data moat specific to Southeast Asia's diabetic population. Once integrated into EMR systems and public health programs, Selfie AI becomes a critical part of the government's screening infrastructure.
| YOLOv5 model on mobile | Real-time AI inference on low-resource devices |
| No specialist needed | Breaks dependency on ophthalmologists |
| RM 10 scan price | 5–10x cheaper than clinics; scalable for government adoption |
| Offline-first architecture | Operates in rural clinics and syncs data later |
This is not just a product. It's a new healthcare layer—built for billions—without needing hospitals. That's Selfie AI's unfair advantage.
Continuous model retraining with localized scans; version upgrades to v2.0+
Build real-time reporting for clinics, NGOs, and government agencies
Apply to WHO, Gates Foundation, ADB, and Malaysian Innovation grants
Integrate alerts and smart triage into patient flows
| Company | Acquired By | Value (USD) |
|---|---|---|
| Zebra Medical Vision | Nanox | Up to $200M |
| Lunit (Acquirer) | Acquired Volpara Health | $193M |
| iCAD Inc. | RadNet | $103M |
| Thirona Retina | Revenio Group | ~$5.2M |
Considering only the high-value deals (Zebra, Lunit's acquisition of Volpara, iCAD):
Average Acquisition Valuation: $165.3M USD
Insight for Investors in Selfie AI:
Benchmark: Early-stage investors (Seed to Series A) in successful digital health exits have realized average return multiples ranging from 5x to 10x.
Benchmark: Approximately 9.5 years on average for acquisitions, with a median of 8 years.
Benchmark: Successful exits in the AI healthcare diagnostics sector have achieved valuations between $300 million and $500 million.
Assuming Selfie AI achieves 10% of the industry average exit valuation:
Projected Exit Valuation: $30 million
Assuming an initial valuation of $3 million, a $30 million exit would yield a 10x return.
Assuming an entry valuation of $10 million, a $30 million exit would yield a 3x return.
YOLOv5 (Medical Optimized)
Mobile-compatible fundus camera
Flutter, NextJS
AWS, Docker, Cognito
HIPAA-compliant, encrypted APIs
Real-time usage dashboards for partners
Domain expertise & Innovation
Operations & Partnerships
Project Director
AI & Clinical Science
Tech Architecture
Product Manager
Chief Scientist
Retinal Specialist
Global Validation
Financial Advisor
| Year | API Revenue (RM) | Leasing (RM) | Total Revenue (RM) |
|---|---|---|---|
| Year 1 | 8M | 2M | 10M |
| Year 2 | 25M | 5M | 30M |
| Year 3 | 42M | 8M | 50M |
USD 300,000
USD 3.5M
Applicable
30%
40%
30%
Your Health. One Selfie Away.
Selfie AI
www.selfieai.world
Email: damo@selfieai.world | raj@selfieai.world
Thank you for your time and consideration